Trial Profile
Randomized, multicenter phase II study evaluating the urodynamic safety of mirabegron in males with lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2012
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 21 Jul 2012 New trial record